# Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)

> **NCT02386839** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 76 (actual)

## Conditions studied

- Retinopathy of Prematurity (ROP)

## Interventions

- **DRUG:** rhIGF-1/rhIGFBP-3

## Key facts

- **NCT ID:** NCT02386839
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-26
- **Primary completion:** 2021-09-28
- **Final completion:** 2021-09-28
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2022-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02386839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02386839, "Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT02386839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*